About

Cancer Care 360

Mission

Sidney Kimmel Cancer Center (SKCC) – Jefferson Health

To improve the lives of cancer patients and their families through compassion, innovation, and breakthrough discoveries.

History

For nearly 25 years, the Sidney Kimmel Cancer Center – Jefferson Health has been a leader in oncology research, patient treatment, and cancer education.

Founded in 1991 as a stand-alone center with a staff of 30, we have grown into a clinical and research enterprise comprising 32 hospitals within our network and practices staffed by hundreds of oncology researchers and physicians from around the globe.

In 1996, with the generous support of Mr. Sidney Kimmel, the cancer center became known as the Kimmel Cancer Center and subsequently renamed the Sidney Kimmel Cancer Center in 2013.

Leadership

Sidney Kimmel Cancer Center Executive Committee

Andrew Chapman, DO, FACP

Interim Enterprise Director, Sidney Kimmel Cancer Center and Executive Vice President of Oncology Services, Jefferson Health

Andrew Chapman, DO, FACP, is the Interim Executive Vice President of Oncology Services at Jefferson Health and Enterprise Director of the Sidney Kimmel Cancer Center, one of only 71 National Cancer Institute (NCI)-designated cancer centers nationwide. Dr. Chapman is currently overseeing cancer services and cancer research at all SKCC – Jefferson Health sites throughout the Greater Philadelphia region, reporting directly to Stephen K. Klasko, MD, MBA, President of Thomas Jefferson University and CEO of Jefferson Health. He is Chief of Cancer Services for SKCC; Co-director of the Jefferson Senior Adult Oncology Center; Professor and Vice Chair of Clinical Operations for the Department of Medical Oncology; and Clinical Professor in the Jefferson College of Nursing.

See Full Bio

Neal Flomenberg, MD
Enterprise Deputy Director for Clinical Integration, Sidney Kimmel Cancer Center

Professor & Chair, Department of Medical Oncology
Director, Blood and Marrow Transplant Program

Andrew Aplin, PhD
Enterprise Deputy Director for Scientific Strategy

Kalbach-Newton Professor in Cancer Research

Matthew Huesser, MBA, DBA
Vice President for Cancer Research Administration

Sidney Kimmel Cancer Center
Follow me on Twitter @CANCERADMIN

Alex Khariton, RTT, MBA
Vice President, Cancer Services

Senior Administrator, Sidney Kimmel Cancer Center

Wm. Kevin Kelly, DO
Enterprise Associate Director for Clinical Research

Professor, Medical Oncology and Urology
Director, Division of Solid Tumor Oncology

Edith Peterson Mitchell, MD
Director, Center to Eliminate Cancer Disparities

Clinical Professor of Medicine and Medical Oncology
Associate Director, Diversity Affairs

Grace Lu-Yao, PhD, MPH
Enterprise Associate Director for Population Science

Vice Chair, Population Science, Department of Medical Oncology

Felix Kim, PhD
Enterprise Associate Director for Training and Education

Associate Professor, Department of Cancer Biology

Amy Leader, PhD, MPH
Enterprise Associate Director for for Community Integration

Director of Community Outreach & Engagement, Sidney Kimmel Cancer Center
Associate Professor, Division of Population Science, Department of Medical Oncology

Ana Maria Lopez, MD, MPH
Enterprise Associate Director for Diversity, Equity, and Inclusion

Professor and Vice Chair, Department of Medical Oncology
Chief of Cancer Services, Sidney Kimmel Cancer Center at Jefferson Health New Jersey

Christopher McNair, PhD
Enterprise Associate Director for Data Science

Director of Cancer Informatics, Sidney Kimmel Cancer Center
Assistant Professor, Department of Cancer Biology

Matthias Schnell, PhD
Enterprise Associate Director for Shared Resources

Professor and Chair, Department of Immunology & Microbiology
Director, Jefferson Vaccine Center

Adam Dicker, MD, PhD
Enterprise SVP, Professor and Chair, Department of Radiation Oncology

Director, Jefferson Center for Digital Health

Leonard Gomella, MD
Senior Director Clinical Affairs, Sidney Kimmel Cancer Center

Bernard W. Godwin Professor of Prostate Cancer and Chair, Department of Urology
Clinical Director, Sidney Kimmel Cancer Network

Matthew Carabasi, MD
Senior Director, Strategic Oncology Partnerships

Professor and Vice Chair of Outreach
Director, Medical Oncology Specialty Network, Department of Medical Oncology

Noreen M. Robertson, DMD
Consortium Liaison, Drexel University

Associate Vice Dean for Research, Drexel University College of Medicine

Mark Shahin, MD
Deputy Director, Asplundh Cancer Pavilion and Oncology Service Line Leader

Director, Hanjani Institute for Gynecologic Oncology
Asplundh Cancer Pavilion, Sidney Kimmel Cancer Center at Abington – Jefferson Health

Emma Laverty
Assistant Vice President of Development

Sidney Kimmel Cancer Center

Peter O'Connor
Administator

Sidney Kimmel Cancer Center

Lauren Riley
Manager, Cancer Marketing Service Line

Sidney Kimmel Cancer Center

Locations

We're everywhere you live, work, and play.

Consortium

Jefferson (Philadelphia University + Thomas Jefferson University) and Drexel University

Through this collaborative, multidisciplinary approach, researchers and clinicians from both institutions work together as they work to advance cancer research and treatment. Infrastructure is supported through integrated program meetings, symposia, participation in cancer center Grand Rounds, use of complementary shared resources, and teleconferencing for research activities among the institutions. Clinical research is guided by the cancer center’s Data Safety and Monitoring Board, formal Multi-Disciplinary Groups, a common Institutional Review Board (IRB) and Protocol Review Committee. The Sidney Kimmel Cancer Center Clinical Trials Office supports all cancer clinical trial activities, and provides public and professional access to the trials at Drexel University and SKCC.

Drexel University formally joined the consortium in 2013, strengthening a long-standing history of collaborative research, publications, and grants between investigators at the universities, most particularly as associated with cancer imaging, hormone-dependent cancers, clinical research, bioinformatics, and population-based studies assessing cancer risk and control. Drexel University also brings substantial strength in biomedical engineering, nanotechnology, and medicinal chemistry.